Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1976
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Basic data given, but considered sufficiently reliable for the purpose of hazard assessment
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reference
Endpoint:
skin irritation: in vivo
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1976
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
other: Documentation insufficient for assessment
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study
Principles of method if other than guideline:
Method according to the typical testing for acute dermal toxicity in a limit test: topical application of substance on rabbits at one high dose.
GLP compliance:
no
Remarks:
pre-GLP
Species:
rabbit
Strain:
not specified
Details on test animals or test system and environmental conditions:
No data
Type of coverage:
not specified
Preparation of test site:
not specified
Vehicle:
unchanged (no vehicle)
Controls:
not required
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 5000 mg/kg bw
Duration of treatment / exposure:
Single treatment (24 h exposure)
Observation period:
14 days
Number of animals:
Total: 10 animals
Details on study design:
no details
Remarks on result:
probability of mild irritation
Irritant / corrosive response data:
- Slight and moderate redness was observed in 6/10 and 4/10 animals, respectively.
- Slight and moderate edema was observed in 1/10 and 9/10 animals, respectively.
Other effects:
- No mortality was observed.

None

Interpretation of results:
study cannot be used for classification
Conclusions:
Under the test conditions, Abies Sibirica Oil induced slight to moderate skin irritation in rabbits.
Executive summary:

In an acute dermal toxicity study, ten rabbits were topically applied with a single dose of Abies Sibirica Oil at 5000 mg/kg bw. All animals were observed for mortality, clinical signs and local reactions.

No mortality occurred at the tested dose level. Slight and moderate redness was observed in 6/10 and 4/10 animals, respectively. Slight and moderate edema was observed in 1/10 and 9/10 animals, respectively.

Under the test conditions, Abies Sibirica Oil induced slight to moderate skin irritation in rabbits.

This study was conducted according to a non-standard method and adequate scoring of skin effects was not provided, therefore it was not possible to take a decision of classification based solely on this study.

Reason / purpose for cross-reference:
reference to other study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976
Report date:
1976

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Standard acute method (limit test)
GLP compliance:
no
Remarks:
pre-GLP
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Fir, Abies sibirica, ext.
EC Number:
294-351-9
EC Name:
Fir, Abies sibirica, ext.
Cas Number:
91697-89-1
Molecular formula:
not applicable
IUPAC Name:
Essential oil of Abies sibirica Ledeb. (Pinaceae) obtained from needles and branches by distillation.
Test material form:
not specified
Details on test material:
- Name of test material (as cited in study report): Abies Sibirica Oil

Test animals

Species:
rat
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
No data

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
not specified
Details on oral exposure:
no details
Doses:
5000 mg/kg bw
No. of animals per sex per dose:
Total: 10 animals
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: Observations for mortality and toxic effects were made daily for 14 days
- Necropsy of survivors performed: No data
Statistics:
None

Results and discussion

Preliminary study:
None
Effect levels
Key result
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: No mortality was observed
Mortality:
- No mortality was observed.
Clinical signs:
- Slightly flaccid muscle tone was observed on Day 1
- Diarrhea and ptosis were observed in some animals from Days 1-3.
Body weight:
No data
Gross pathology:
No data
Other findings:
None

Any other information on results incl. tables

None

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the test conditions, the oral LD50 for test item is higher than 5000 mg/kg bw in rats therefore it must not be classified according to the CLP Regulation (EC) No. 1272/2008 and Globally Harmonized System (GHS).
Executive summary:

In an acute oral toxicity study (limit test), ten rats were given a single oral dose of Abies Sibirica Oil at 5000 mg/kg bw. Animals were observed for mortality and clinical signs for 14 days.

No mortality was observed. Slightly flaccid muscle tone was observed on Day 1. Diarrhea and ptosis were observed in some animals from Days 1-3. In this study, the oral LD50 of Abies Sibirica Oil was higher than 5000 mg/kg bw in rats.

Under the test conditions, oral LD50 of Abies Sibirica Oil is higher than 5000 mg/kg bw in rats therefore it is not classified according the CLP Regulation (EC) No. 1272/2008 and Globally Harmonized System (GHS).

This study is considered as acceptable and satisfies the requirement for acute oral toxicity endpoint.